Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hamps BioBOM:544312 -2.17%12 PB Ratio is 2.42 as of Aug. 20, 2026, which is 4% below its 10-year median of 2.52. GuruFocus rates BOM:544312 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 610 Healthcare Providers & Services companies, Hamps Bio ranks worse than 57.54% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-20), Hamps Bio's share price is ₹22.50. Hamps Bio's Book Value per Share for the quarter that ended in Mar. 2026 was ₹9.30. Hence, Hamps Bio's PB Ratio of today is 2.42.
The historical rank and industry rank for Hamps Bio's PB Ratio or its related term are showing as below:
BOM:544312'
s PB Ratio Range Over the Past 10 Years
Min: 1.64 Med: 2.52 Max: 13.25
Current: 2.42
During the past 5 years, Hamps Bio's highest PB Ratio was 13.25. The lowest was 1.64. And the median was 2.52.
BOM:544312's PB Ratio is ranked worse than 57.54% of 610
companies
in the Healthcare Providers & Services industry
Industry Median: 1.95
vs BOM:544312: 2.42
During the past 12 months, Hamps Bio's average Book Value Per Share Growth Rate was -7.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 81.10% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Hamps Bio was 106.10% per year. The lowest was 81.10% per year. And the median was 93.60% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Hamps Bio PB Ratio Related Terms
Hamps Bio PB Ratio Historical Data
* Premium members only.
The historical data trend for Hamps Bio's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Hamps Bio's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hamps Bio PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hamps Bio's PB Ratio distribution charts can be found below:
* The bar in red indicates where Hamps Bio's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Hamps Bio's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Hamps Bio (BOM:544312) has a PB Ratio of 2.42 as of Aug. 20, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hamps Bio and its competitors. This is near median its historical median of 2.52. Over the past decade, Hamps Bio's PB Ratio has ranged from 1.64 to 13.25. According to the industry distribution chart, Hamps Bio ranks #351 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 57.5%.
Is Hamps Bio's PB Ratio too high?
Hamps Bio's current PB Ratio of 2.42 is near median its 10-year median of 2.52. Over the past 10 years, this metric has ranged from a low of 1.64 to a high of 13.25. The Healthcare Providers & Services industry median PB Ratio is 1.95. Hamps Bio's value of 2.42 is 24.1% above this industry median. Based on the distribution chart, Hamps Bio ranks #351 out of 610 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Hamps Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Hamps Bio's PB Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Hamps Bio ranks #351 out of 610 companies for PB Ratio. This places Hamps Bio in the lower half of its industry. The industry median PB Ratio is 1.95. Hamps Bio's value of 2.42 is 24.1% above this benchmark. Historically, Hamps Bio's own PB Ratio has ranged from 1.64 to 13.25 over the past decade. While the company's 10-year median is 2.52 vs. the industry median of 1.95, Hamps Bio has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.95, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hamps Bio's current PB Ratio of 2.42 is 24.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hamps Bio and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hamps Bio's current PB Ratio is 2.42, which is near median its own 10-year median of 2.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hamps Bio stock overvalued right now?
Hamps Bio (BOM:544312) has a current PB Ratio of 2.42. The current PB Ratio is 2.42, which is near median its 10-year median of 2.52 and 24.1% above the Healthcare Providers & Services industry median of 1.95. Hamps Bio's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Hamps Bio (BOM:544312), the current PB Ratio is 2.42 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hamps Bio Ltd is engaged in the ethical marketing and distribution of pharmaceutical formulation products. Its product include tablets, syrups, capsules, injectables, oil, gel and powder used as medicine and nutrition supplements as well as the manufacturing of freeze dried and frozen products such as fruits, vegetables, herbs and flowers. The company segment includes Manufacturing, trading and distribution of Pharmaceutical formulation products and Manufacturing of Freeze dried and frozen products like fruits, vegetables, herbs, flowers, etc. Key revenue is generated from Medicine Products.
12GF Score
Get the complete analysis for BOM:544312
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544312 has been successfully added to your 
